Oruka Therapeutics, Inc. ( ORKA) - Stock Earnings
ORKA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -30.3 million USD | — USD |
| 2025Q4 | -29.6 million USD | — USD |
| 2026Q1 | -31.8 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ORKA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -5.3 million USD | — USD |
| 2024 | -83.7 million USD | — USD |
| 2025 | -105.4 million USD | — USD |
| 2026 Est. | — | — |
ORKA
Price: $68.86
52 week price:
Dividend Yield: 32.18%
Earnings Per Share: -1.93 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.3 billion